Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/171063
Title: pi-Donor/pi-Acceptor Interactions for the Encapsulation of Neurotransmitters on Functionalized Polysilicon-Based Microparticles
Author: Giraldo, Sandra
Alea Reyes, María Elisa
Limón, David
González, Asensio
Duch, Marta
Plaza, José A.
Ramos López, David
Lapuente Pérez, Joaquín de
González Campo, Arántzazu
Pérez García, M. Lluïsa (Maria Lluïsa)
Keywords: Neurotransmissors
Dispositius d'administració de medicaments
Neurotransmitters
Drug delivery devices
Issue Date: 1-Aug-2020
Publisher: MDPI
Abstract: Bipyridinium salts, commonly known as viologens, are π-acceptor molecules that strongly interact with π-donor compounds, such as porphyrins or amino acids, leading their self-assembling. These properties have promoted us to functionalize polysilicon microparticles with bipyridinium salts for the encapsulation and release of π-donor compounds such as catecholamines and indolamines. In this work, the synthesis and characterization of four gemini-type amphiphilic bipyridinium salts (1·4PF6-4·4PF6), and their immobilization either non-covalently or covalently on polysilicon surfaces and microparticles have been achieved. More importantly, they act as hosts for the subsequent incorporation of π-donor neurotransmitters such as dopamine, serotonin, adrenaline or noradrenaline. Ultraviolet-visible absorption and fluorescence spectroscopies and high-performance liquid chromatography were used to detect the formation of the complex in solution. The immobilization of bipyridinium salts and neurotransmitter incorporation on polysilicon surfaces was corroborated by contact angle measurements. The reduction in the bipyridinium moiety and the subsequent release of the neurotransmitter was achieved using ascorbic acid, or Vitamin C, as a triggering agent. Quantification of neurotransmitter encapsulated and released from the microparticles was performed using high-performance liquid chromatography. The cytotoxicity and genotoxicity studies of the bipyridinium salt 1·4PF6, which was selected for the non-covalent functionalization of the microparticles, demonstrated its low toxicity in the mouse fibroblast cell line (3T3/NIH), the human liver carcinoma cell line (HepG2) and the human epithelial colorectal adenocarcinoma cell line (Caco-2). View Full-
Note: Reproducció del document publicat a: https://doi.org/10.3390/pharmaceutics12080724
It is part of: Pharmaceutics, 2020, vol. 12, num. 8, p. 724-743
URI: http://hdl.handle.net/2445/171063
Related resource: https://doi.org/10.3390/pharmaceutics12080724
ISSN: 1999-4923
Appears in Collections:Articles publicats en revistes (Institut de Nanociència i Nanotecnologia (IN2UB))
Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)

Files in This Item:
File Description SizeFormat 
703327.pdf3.23 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons